Recon: FDA places Legend Biotech's early-stage CAR-T on hold; L...

02/15/22

Recon: FDA places Legend Biotech's early-stage CAR-T on hold; Lilly reunites with Immunogen with ADC deal Regulatory Focus

[more]

Feeds Categories: